Taken together, these results demonstrate that E-cadherin acts as a crucial suppressor of ovarian cancer invasiveness, and along with other described mechanisms, the loss of E-cadherin plays an important role in FGF2-induced cell invasion. This evidence concerns the gene FGF2 and ovarian carcinoma.